Cargando…
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
Nearly 500’000 fatalities due to COVID-19 have been reported globally and the death toll is still rising. Most deaths are due to acute respiratory distress syndrome (ARDS), as a result of an excessive immune response and a cytokine storm elicited by severe SARS-CoV-2 lung infection, rather than by a...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372209/ https://www.ncbi.nlm.nih.gov/pubmed/32696426 http://dx.doi.org/10.1007/s12015-020-10004-x |